0001209191-18-005145.txt : 20180124
0001209191-18-005145.hdr.sgml : 20180124
20180124164305
ACCESSION NUMBER: 0001209191-18-005145
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180122
FILED AS OF DATE: 20180124
DATE AS OF CHANGE: 20180124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALDRICH RICHARD
CENTRAL INDEX KEY: 0001185039
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36310
FILM NUMBER: 18545734
MAIL ADDRESS:
STREET 1: 1365 MAIN STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001367920
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-860-0045
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060628
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-22
0
0001367920
CONCERT PHARMACEUTICALS, INC.
CNCE
0001185039
ALDRICH RICHARD
C/O CONCERT PHARMACEUTICALS, INC.
99 HAYDEN AVENUE, SUITE 500
LEXINGTON
MA
02421
1
0
0
0
Common Stock
2018-01-22
4
S
0
5000
19.55
D
36946
I
See Footnote
Common Stock
2018-01-22
4
S
0
5000
19.54
D
57405
I
See Footnote
Common Stock
2018-01-23
4
S
0
5000
19.67
D
31946
I
See Footnote
Common Stock
2018-01-23
4
S
0
5000
19.68
D
52405
I
See Footnote
Common Stock
2018-01-24
4
S
0
5000
19.83
D
26946
I
See Footnote
Common Stock
2018-01-24
4
S
0
5000
19.83
D
47405
I
See Footnote
Common Stock
286975
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on December 13, 2017.
The range of prices for the transaction reported on this line was $19.41 to $19.82. The average weighted price was $19.55. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares held by Little Bear Associates, Inc., formerly known as RA Capital Associates, Inc. Mr. Aldrich is the sole stockholder of Little Bear Associates, Inc.
The range of prices for the transaction reported on this line was $19.37 to $19.84. The average weighted price was $19.54. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of Mr. Aldrich's minor children. The trustees of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
The range of prices for the transaction reported on this line was $19.47 to $19.85. The average weighted price was $19.67. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range of prices for the transaction reported on this line was $19.47 to $19.85. The average weighted price was $19.68. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range of prices for the transaction reported on this line was $19.61 to $20.00. The average weighted price was $19.83. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/Nancy Stuart as attorney-in-fact for Richard Aldrich
2018-01-24